School of Medicine
Showing 11-20 of 87 Results
-
Haijing Wu Hallenbeck
Postdoctoral Research Fellow, Psychiatry
BioHaijing Hallenbeck, Ph.D., is a postdoctoral fellow at the National Center for PTSD at VA Palo Alto Health Care System, in conjunction with Stanford University School of Medicine. After completing her internship at VA Palo Alto Health Care System, she earned her Ph.D. in clinical psychology from Washington University in St. Louis. Haijing's graduate work focused on using mobile app technology for the assessment of depression. As a postdoctoral fellow, she is investigating how this technology can be adapted for purposes of treatment, particularly for PTSD and depression. She is interested in optimizing mobile apps to improve both mental health symptoms and psychosocial functioning for individuals.
-
Meghan Halley
Research Scholar, School of Medicine - Biomedical Ethics
BioI am a medical anthropologist with a background in public health and a passion for research that engages the voices of patients and families in improving population health and healthcare delivery. I am a proud Midwesterner, with a B.A. in anthropology from the University of Wisconsin-Madison, and a PhD and MPH from Case Western Reserve University in Cleveland, Ohio. My broad research interests include the psychosocial dimensions of health and illness, the well-being of children and families, and medical decision-making, particularly in the context of complex illness. I also am a perpetual student of the art of grant writing, and I love supporting scientists in developing this critical skill. At the Center for Biomedical Ethics, my research examines the ethical and economic implications of genome sequencing for diagnosis of children with rare diseases and their families. My work examines the ethical implications of varying approaches to economic evaluation and their relation to reimbursement and equitable access to new genomic technologies. I am also interested in the development of new tools for measurement of the costs and benefits of new genomic technologies that reflect patient values.
